• Printer Friendly
  • Text Resizer - Small
  • Text Resizer - Large
  • Email this page

Generic medicines and brand substitutionNPS News 44: Generic prescription medicines and brand substitution

Description: Examines bioequivalence (and how it is assessed) critical dose medicines, and ways to communicate information to patients about generic medicines and brand substitution.

Download Adobe Acrobat Reader

This document is a PDF file. To view PDF documents you will need to download Adobe Reader from the Adobe website.

Please don't show me this PDF gateway page again for this browser session (this will reset when the browser is closed).

Date published: 2006-02-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.